After Ocaliva: US FDA Sees Breakthrough Potential In New Approaches To Liver Disease

 
• By Bridget Silverman
  
liver
New approaches to liver disease could advance the field significantly. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from United States